19-17235954-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_005234.4(NR2F6):c.485C>T(p.Pro162Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000872 in 1,479,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000093 ( 0 hom. )
Consequence
NR2F6
NM_005234.4 missense
NM_005234.4 missense
Scores
2
1
16
Clinical Significance
Conservation
PhyloP100: 3.97
Genes affected
NR2F6 (HGNC:7977): (nuclear receptor subfamily 2 group F member 6) Enables DNA-binding transcription factor activity and sequence-specific double-stranded DNA binding activity. Involved in negative regulation of transcription by RNA polymerase II. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.37177974).
BS2
High AC in GnomAd4 at 5 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NR2F6 | ENST00000291442.4 | c.485C>T | p.Pro162Leu | missense_variant | 3/4 | 1 | NM_005234.4 | ENSP00000291442.2 | ||
ENSG00000269095 | ENST00000594059.1 | c.125C>T | p.Pro42Leu | missense_variant | 5/5 | 4 | ENSP00000473056.1 | |||
NR2F6 | ENST00000596878.1 | c.125C>T | p.Pro42Leu | missense_variant | 3/3 | 3 | ENSP00000471686.1 |
Frequencies
GnomAD3 genomes AF: 0.0000331 AC: 5AN: 151144Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
5
AN:
151144
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000338 AC: 3AN: 88706Hom.: 0 AF XY: 0.0000199 AC XY: 1AN XY: 50316
GnomAD3 exomes
AF:
AC:
3
AN:
88706
Hom.:
AF XY:
AC XY:
1
AN XY:
50316
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000934 AC: 124AN: 1328144Hom.: 0 Cov.: 33 AF XY: 0.0000946 AC XY: 62AN XY: 655358
GnomAD4 exome
AF:
AC:
124
AN:
1328144
Hom.:
Cov.:
33
AF XY:
AC XY:
62
AN XY:
655358
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000331 AC: 5AN: 151144Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 73846
GnomAD4 genome
AF:
AC:
5
AN:
151144
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
73846
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 02, 2024 | The c.485C>T (p.P162L) alteration is located in exon 3 (coding exon 3) of the NR2F6 gene. This alteration results from a C to T substitution at nucleotide position 485, causing the proline (P) at amino acid position 162 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.;.
REVEL
Benign
Sift
Benign
T;.;.
Sift4G
Benign
T;.;.
Polyphen
B;.;.
Vest4
MutPred
Gain of catalytic residue at P162 (P = 0.0329);.;.;
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at